A novel medication has the potential to moderate the swift advancement of Parkinson's disease.

Published Date: 17 Apr 2024

An exploratory analysis of data from a has shown that the monoclonal antibody prasinezumab reduces signs of motor deterioration in patients with Parkinson's disease (PD) who are experiencing rapid disease progression.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mobile prostate cancer screening clinic can ID the disease in disadvantaged men

2.

Clinical trial is testing whether heavy lifting could combat cancer side effects

3.

NIH research cuts leave cancer patient facing hard choice

4.

Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.

5.

A video animation guide to assist young people who are fatigued from cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot